Health Canada drug identification number

DIN 02439409 — ROPIVACAINE HYDROCHLORIDE INJECTION, USP 10 MG

ROPIVACAINE HYDROCHLORIDE INJECTION, USP is a solution of Ropivacaine marketed by FRESENIUS KABI CANADA LTD. The full Ropivacaine monograph covers indications, dosing, interactions and counselling for every strength and manufacturer.

DIN
02439409
Brand name
ROPIVACAINE HYDROCHLORIDE INJECTION, USP
Active ingredient
Ropivacaine
Strength
10 MG
Dosage form
SOLUTION
Route
EPIDURAL
Manufacturer
FRESENIUS KABI CANADA LTD
Health Canada status
MARKETED
Drug class
Local anesthetic (amide type)

Product data from the Health Canada Drug Product Database, synced . Verify the live status at Health Canada.

Other Ropivacaine products

DINBrandStrengthFormManufacturerStatus
02229418 NAROPIN 10 MG SOLUTION ASPEN PHARMACARE CANADA INC. MARKETED
02229411 NAROPIN 2 MG SOLUTION ASPEN PHARMACARE CANADA INC. MARKETED
02229415 NAROPIN 5 MG SOLUTION ASPEN PHARMACARE CANADA INC. MARKETED
02439379 ROPIVACAINE HYDROCHLORIDE INJECTION, USP 2 MG SOLUTION FRESENIUS KABI CANADA LTD MARKETED
02439387 ROPIVACAINE HYDROCHLORIDE INJECTION, USP 5 MG SOLUTION FRESENIUS KABI CANADA LTD MARKETED

Rejoining the server...

Rejoin failed... trying again in seconds.

Failed to rejoin.
Please retry or reload the page.

The session has been paused by the server.

Failed to resume the session.
Please retry or reload the page.